Tomarong, Hazel .
HRN: 09-92-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/16/2023
06/18/2023
IV
500
Q8
1° LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes